Diabetes mellitus, a complex metabolic disorder with rising global prevalence, has been a subject of clinical attention in many traditional systems of medicine, including Unani medicine. This review explores the diagnostic concepts of diabetes within Unani medicine, contrasting them with contemporary biomedical approaches. Through scientific analysis, we examine the classical Unani understanding of diabetes, its etiology, risk factors, clinical manifestations, diagnostic protocols, and therapeutic strategies, while also highlighting the integration of recent evidence and guideline-based recommendations. The article aims to provide clinicians and researchers with a nuanced appreciation of the Unani diagnostic paradigm, emphasizing its historical roots, practical implications, and relevance in modern diabetes care.
Diabetes mellitus represents a major healthcare challenge worldwide, characterized by chronic hyperglycemia resulting from defects in insulin secretion, insulin action, or both. While modern medicine has advanced in the understanding and management of diabetes, traditional medical systems such as Unani medicine offer a distinctive perspective, grounded in centuries-old principles and clinical observations. Unani medicine, rooted in Greco-Arabic traditions, conceptualizes diseases based on humoral theory and individualized patient assessment. Its classical texts provide detailed descriptions of diabetes, referred to as "Dular" or "Ziabetes", and elaborate on its causation, progression, and management. This review systematically examines the diagnostic concepts of diabetes in Unani medicine, contextualizing them within current scientific knowledge for the benefit of healthcare professionals.
Globally, the prevalence of diabetes is escalating at an alarming rate, with the International Diabetes Federation estimating that over 537 million adults were living with diabetes in 2021. This surge is most pronounced in low- and middle-income countries, where both type 1 and type 2 diabetes contribute to significant morbidity and mortality. Unani classical literature, while not providing epidemiological statistics in the modern sense, recognized the growing burden of "Ziabetes" centuries ago. The writings of Avicenna (Ibn Sina) and Al-Razi allude to its increasing frequency, particularly among certain populations and lifestyle patterns. In contemporary practice, Unani physicians encounter a high proportion of diabetes cases, especially in regions where Unani medicine is widely practiced, such as South Asia and the Middle East. The increasing disease burden highlights the need to integrate evidence-based diagnostic and management strategies across all medical traditions.
In Unani medicine, the pathophysiology of diabetes is interpreted through the lens of humoral imbalance, particularly an excess of "Safra" (yellow bile) and "Balgham" (phlegm), with a corresponding weakening of the renal and hepatic faculties. Classical texts describe "Ziabetes" as a disorder of "Tabiyat" (the body's inherent power of self-preservation) leading to excessive production and excretion of urine. This is attributed to the inability of organs, principally the liver and kidneys, to properly process and assimilate nutrients, resulting in the loss of fluids and metabolic dysregulation. Modern biomedical science, by contrast, identifies insulin deficiency or resistance as the central mechanism. Notably, recent studies have sought to correlate Unani concepts with contemporary molecular and metabolic understanding, suggesting that the Unani notions of "Hararat-e-Ghareeziya" (innate heat) and "Quwate Hazma" (digestive power) may be analogues for metabolic rate and pancreatic function, respectively.
Unani medicine identifies several predisposing factors for diabetes, many of which align with modern risk factors. These include a sedentary lifestyle, excessive consumption of sweet or rich foods, obesity, hereditary predisposition, emotional stress, and chronic illnesses that weaken the major organs. Classical scholars emphasized the role of "obesity of the liver" (Kubra Kabid) and "weakness of the kidneys" as central to the development of diabetes. Modern epidemiological studies confirm that obesity, physical inactivity, family history, and certain ethnicities are major risk factors for type 2 diabetes. The convergence of these risk factors across medical systems underscores the enduring validity of Unani observations and their relevance in contemporary risk stratification and prevention strategies.
The hallmark clinical features of diabetes in Unani medicine closely mirror those recognized today. Polyuria (excessive urination), polydipsia (excessive thirst), and weight loss are consistently described in classical texts. Unani physicians also noted symptoms such as dry mouth, sweet-tasting urine, generalized weakness, and delayed wound healing. The presence of "sweetness" in urine was used as a diagnostic clue, often confirmed by tasting or observing the attraction of ants to the patient's urine. Contemporary clinical features of diabetes extend to blurred vision, recurrent infections, neuropathy, and cardiovascular complications. The overlap in symptomatology between Unani and modern medicine underscores the accuracy of clinical observation and the universality of diabetes manifestations across cultures and eras.
Diagnostic protocols in Unani medicine are rooted in a holistic patient assessment, with a strong emphasis on clinical history, symptomatology, and examination of urine. The classical approach involves detailed questioning regarding urinary frequency, thirst, dietary habits, and weight changes. Urinalysis is central, with physicians assessing the volume, color, and taste of urine, as well as its effect on insects. The pulse, tongue, and general physical condition are also evaluated for signs of humoral imbalance. While these methods lack the specificity and sensitivity of modern biochemical assays, they provided a pragmatic diagnostic framework for centuries. Today, diagnosis of diabetes relies on standardized criteria, including fasting plasma glucose, oral glucose tolerance test, and HbA1c measurements. There is growing interest in integrating traditional diagnostic wisdom with modern laboratory techniques to enhance early detection, especially in resource-limited settings.
Unani management of diabetes is based on restoring humoral balance and strengthening the principal organs, particularly the liver and kidneys. Therapeutic interventions include dietary modification (Ilaj bil Ghiza), lifestyle regulation (Ilaj bil Tadbeer), pharmacotherapy with herbal and mineral formulations (Ilaj bil Dawa), and, in rare cases, surgical interventions (Ilaj bil Yad). Dietary recommendations emphasize avoidance of sweet, oily, or heavy foods, with a preference for light, easily digestible meals. Physical activity, moderate exercise, and stress reduction are integral components. Pharmacological agents commonly used include seeds of Trigonella foenum-graecum (fenugreek), Momordica charantia (bitter melon), and other antidiabetic herbs. Contemporary studies have demonstrated the hypoglycemic potential of several Unani formulations, supporting their adjunctive use in diabetes management. However, integration with modern therapies and individualized patient care remains essential for optimal outcomes.
Recent advances in Unani diabetes care include the standardization of herbal formulations, in vitro and in vivo evaluation of hypoglycemic agents, and clinical trials assessing efficacy and safety. Efforts are underway to elucidate the molecular mechanisms of action for key Unani antidiabetic herbs, with promising results for compounds such as charantin, trigonelline, and gymnemic acids. Emerging therapies focus on synergizing Unani pharmacotherapy with modern antidiabetic drugs, enhancing patient adherence, and minimizing adverse effects. Digital health tools and telemedicine platforms are also being explored to facilitate Unani diabetes care delivery, particularly in remote and underserved populations.
Unani regulatory bodies and academic institutions have developed clinical guidelines for the diagnosis and management of diabetes, emphasizing the importance of early detection, patient education, and comprehensive care. These guidelines advocate for integrating Unani diagnostic protocols with modern laboratory investigations, individualized risk assessment, and evidence-based herbal pharmacotherapy. Multidisciplinary collaboration with endocrinologists, dietitians, and primary care physicians is recommended to ensure holistic and safe diabetes management. Patient monitoring, regular follow-up, and outcome assessment are essential components of guideline-based practice.
Unani medicine offers a rich, historically grounded framework for understanding and diagnosing diabetes, with concepts that continue to resonate with modern clinical practice. Its emphasis on holistic patient assessment, lifestyle modification, and natural therapeutics provides valuable insights for integrative diabetes care. By harmonizing Unani diagnostic wisdom with contemporary scientific advances and guideline-based management, healthcare professionals can enhance patient outcomes and contribute to the evolving landscape of diabetes care.
1.
Pancreatic cancer patients who were prescribed lorazepam for anxiety had poorer survival rates.
2.
Study reveals crucial gaps in oral cancer awareness in Middle East and North Africa
3.
From 40 to 74, the US Preventive Services Task Force advises every two years for screening mammography.
4.
A new drug delivery system may help patients with a rare eye cancer
5.
Chicken Broth Recall; Medicaid at Risk; Princess Kate Thanks Medical Staff
1.
Clonal Hematopoiesis and Healthy Aging: Clinical Implications, Mechanisms, and Emerging Perspectives
2.
Cemiplimab: A Revolutionary Drug For Treating Cancer
3.
Revolutionizing Cancer Treatment: The Promise of Bevacizumab Injections
4.
Beyond the Blood: Expanding CAR T-Cell Therapy to Solid Tumors- A New Era of Precision Oncology
5.
Unlocking the Benefits of Eltrombopag: A Comprehensive Guide
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV
3.
Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients
4.
Navigating the Complexities of Ph Negative ALL - Part XV
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation